Search

Displaying results 4761 - 4770 of 10000 in total
  1. Drug

    XL228

    go.drugbank.com/drugs/DB05184
    Investigational

    XL228 is a novel anticancer compound designed to inhibit the insulin-like growth factor type-1 receptor (IGF1R), Src and Abl tyrosine kinases – targets that play crucial roles in cancer cell proliferation

  2. Drug

    Mus musculus skin

    go.drugbank.com/drugs/DB10412
    Approved

    Mus musculus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  3. Drug

    Cavia porcellus skin

    go.drugbank.com/drugs/DB10416
    Approved

    Cavia porcellus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  4. Drug

    Meriones unguiculatus skin

    go.drugbank.com/drugs/DB10603
    Approved

    Meriones unguiculatus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  5. Drug

    Capra hircus skin

    go.drugbank.com/drugs/DB10604
    Approved

    Capra hircus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  6. Drug

    Oryctolagus cuniculus skin

    go.drugbank.com/drugs/DB10607
    Approved

    Oryctolagus cuniculus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  7. Drug

    Rilapladib

    go.drugbank.com/drugs/DB05119
    Investigational

    Rilapladib is the third genomics-derived small molecule drug arising from the Human Genome Sciences-GlaxoSmithKline collaboration to enter clinical development. … It is a lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques.

  8. Drug

    Pazopanib

    go.drugbank.com/drugs/DB06589
    ApprovedInvestigational

    Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.

  9. Drug

    IL-2 pDNA

    go.drugbank.com/drugs/DB05935
    Experimental

    Vical incorporated has initiated a human Phase 1 study of an investigational method of delivering interleukin-2 (IL-2), a potent immune system stimulant, for patients with recurrent metastatic melanoma

    Synonyms: IL-2 pDNA
  10. Drug

    XMT-1001

    go.drugbank.com/drugs/DB06069
    Investigational

    XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human tumor xenografts models … In this novel CPT pro-drug, CPT is conjugated with a 70 kDa biodegradable hydrophilic polyacetal, poly (1-hydroxymethylene hydroxylmethylformal).

    Categories: Compounds used in a research, industrial, or household setting